United in Fight against prOstate cancer registry (UFO): Treatment patterns and quality of life from a large, multi-center, longitudinal cohort study in Asia

被引：0
|
作者：
Kanesvaran, R. [1 ]
Uemura, H. [2 ]
Ye, D. [3 ]
Chiong, E. [4 ]
Lojanapiwat, B. [5 ]
Pu, Y-S. [6 ]
Rawal, S. Kumar [7 ]
Razack, A. H. A. [8 ]
Zeng, H. [9 ]
Chung, B. H. [10 ,11 ]
Tsai, Y-S. [12 ]
Ashani, M. Y. Noor [13 ]
Liu, Y. [14 ]
Asinas-Tan, M. [15 ]
Liu, W. [16 ]
Low, G. K. M. [17 ]
Losio, M. van Kooten [18 ]
机构：
[1] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore
[2] Kindai Univ Hosp, Fac Med, Osaka, Japan
[3] Fudan Univ, Dept Urol, Shang Hai Canc Ctr, Shanghai, Peoples R China
[4] Natl Univ Hlth Syst, Dept Urol, Singapore, Singapore
[5] Chiang Mai Univ, Div Urol, Fac Med, Chiang Mai, Thailand
[6] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan
[7] Rajeev Gandhi Canc Inst, Genitourooncol Serv, New Delhi, India
[8] Univ Malaya, Dept Surg, Fac Med, Kuala Lumpur, Malaysia
[9] Sichuan Univ, Dept Urol, West China Hosp, Chengdu, Sichuan, Peoples R China
[10] Yonsei Univ, Coll Med, Dept Urol, Gangnam Severance Hosp, Seoul, South Korea
[11] Yonsei Univ, Coll Med, Urol Sci Inst, Gangnam Severance Hosp, Seoul, South Korea
[12] Natl Cheng Kung Univ Hosp, Dept Urol, Tainan, Taiwan
[13] Hosp Kuala Lumpur, Inst Urol & Nephrol, Dept Urol, Kuala Lumpur, Malaysia
[14] Janssen Res & Dev, Epidemiol, Raritan, NJ USA
[15] Janssen Med Affairs, Epidemiol, Singapore, Singapore
[16] Janssen China Res & Dev Ctr, SDS China Dept, Shanghai, Peoples R China
[17] Janssen, Med Affairs, Singapore, Singapore
[18] Janssen, Med Affairs Asia Pacific, Sydney, NSW, Australia
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
212O
引用
收藏
页数：1
相关论文
共 33 条
  • [21] Quality of life changes over time and predictors in a large head and neck patients' cohort: secondary analysis from an Italian multi-center longitudinal, prospective, observational study-a study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group
    Vigano, Anna
    De Felice, Francesca
    Iacovelli, Nicola Alessandro
    Alterio, Daniela
    Ingargiola, Rossana
    Casbarra, Alessia
    Facchinetti, Nadia
    Oneta, Olga
    Bacigalupo, Almalina
    Tornari, Elena
    Ursino, Stefano
    Paiar, Fabiola
    Caspiani, Orietta
    Di Rito, Alessia
    Musio, Daniela
    Bossi, Paolo
    Steca, Patrizia
    Jereczek-Fossa, Barbara Alicja
    Caso, Letizia
    Palena, Nicola
    Greco, Andrea
    Orlandi, Ester
    [J]. SUPPORTIVE CARE IN CANCER, 2023, 31 (04)
  • [22] Low-Grade Dysplasia (LGD) Is a Poor Marker for Cancer Progression in Patients with Barrett's Esophagus (BE): Preliminary Results from a Large, Multi-Center, Cohort Study
    Wani, Sachin B.
    Falk, Gary W.
    Sampliner, Richard E.
    Wang, Amy
    Young, Patrick E.
    Lieberman, David A.
    Bansal, Ajay
    Cash, Brooks D.
    Singh, Mandeep
    Singh, Vikas
    Higbee, April D.
    Hall, Matthew
    Rastogi, Amit
    Sharma, Prateek
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A592 - A592
  • [23] IMPROVED QUALITY OF LIFE AND SEXUAL FUNCTION FOLLOWING BULKAMID TREATMENT: PATIENT SUBJECTIVE OUTCOME DATA FROM A SINGLE-MASKED, RANDOMIZED, MULTI-CENTER, COMPARATIVE STUDY
    Sokol, E. R.
    Karram, M.
    Dmochowski, R.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2014, 25 : S128 - S129
  • [24] Potential reduction of over treatment of localized prostate cancer using a cell cycle gene expression assay (Prolaris) in biopsy specimens: Results from the European multi-center EMPATHY-P study
    Kwiatkowski, M.
    Daniele, L.
    Albers, P.
    Correa Generoso, R.
    Angeles Cabeza, M.
    McNeill, A.
    Hayward, C. R. W.
    Moore, C.
    Copeland, K.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S505 - S505
  • [25] Effectiveness, Safety and Quality of Life with Tofacitinib Treatment in Adult Patients with Rheumatoid Arthritis Under Routine Clinical Care: First Interim Results from a German Non-Interventional, Prospective, Multi-Center Study
    Behrens, Frank
    Prothmann, Ulrich
    Klopsch, Thilo
    Holst, Ann-Doerthe
    Blindzellner, Lisa
    Behmer, Olaf
    Klaus, Pascal
    Meng, Thomas
    Loeschmann, Peter-Andreas
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [26] IMPACT ON HEALTH RELATED QUALITY OF LIFE OF RETROPUBIC RADICAL PROSTATECTOMY, EXTERNAL BEAM RADIOTHERAPY, AND BRACHYTHERAPY AS TREATMENT OF PROSTATE CANCER: RESULTS AT 3 YEARS FOLLOW-UP OF A PROSPECTIVE, LONGITUDINAL AND MULTI-INSTITUTIONAL STUDY
    Novo, Suarez J. F.
    Aguilo, F.
    Ferrer, M.
    Guedea, F.
    Fernandez, P.
    Craven-Bratle, J.
    Herruzo, I.
    Hervas, A.
    Macias, V.
    Marino, A.
    Ortiz, M. J.
    Villavicencio, H.
    Franco, E.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 308 - 308
  • [27] Osemitamab in combination with capecitabine and oxaliplatin (CAPOX) as a first line treatment of advanced G/GEJ cancer: Updated data of cohort C from a phase I/IIa, multi-center study (TranStar102/TST001-1002)
    Shen, Lin
    Liu, Dan
    Li, Ning
    Guo, Weijian
    Liu, Tianshu
    Li, Hongli
    Li, Jiayi
    Bai, Yuxian
    Deng, Yanhong
    Zhuang, Zhi-xiang
    Sun, Meili
    Fan, Qingxia
    Zhao, Fuyou
    Han, Liang
    Xia, Zhenzhong
    Wang, Jianming
    Qi, Charlie
    Xu, Li
    Qian, Xueming
    Germa, Caroline
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for localized prostate cancer: A short-term evaluation of five approaches from a single institution
    Ball, Adam J.
    Gambill, Bethany
    Fabrizio, Michael D.
    Davis, John W.
    Given, Robert W.
    Lynch, Donald F.
    Shaves, Mark
    Schellhammer, Paul F.
    [J]. JOURNAL OF ENDOUROLOGY, 2006, 20 (10) : 723 - 731
  • [29] Anlotinib combined with penpulimab as first-line treatment for persistent, recurrent, or metastatic cervical cancer: Preliminary results from ALTER-GO-020, a single-arm, open-label, multi-cohort, multi-center phase II clinical study.
    Wang, Dengfeng
    Liu, Hong
    Chen, Lihong
    He, Mian
    Zhao, Weidong
    Xiang, Yang
    Zhang, Guonan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Results from a multi-center, open-label, phase II study investigating the combination of RAD001 (everolimus) with paclitaxel and carboplatin in first line treatment of patients with advanced (stage IV) large cell lung cancer with neuroendocrine differentiation (LCNEC)
    Engel-Riedel, W.
    Grohe, C.
    Kropf-Sanchen, C.
    von Pawel, J.
    Guetz, S.
    Kollmeier, J.
    Eberhardt, W.
    Christopoulos, P.
    Nimmrich, I
    Sieder, C.
    Baum, V
    Serke, M.
    Thomas, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 88 - 88
1234